Aspire Biopharma Holdings Total Current Liabilities

Aspire Biopharma Holdings (ASBP) currently reports a total current liabilities of $1.7M as of June 2026. That compares with $11M in the prior-year period — down 84.0% year over year. Use the charts on this page to explore Aspire Biopharma Holdings's total current liabilities history and peer comparisons.

Aspire Biopharma Holdings's total current liabilities decreased from $11M to $1.7M — a 84.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Aspire Biopharma Holdings reported $1.7M in total current liabilities as of June 2026. That compares with $11M in the prior-year period — down 84.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $1.7M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Aspire Biopharma Holdings, and consider following ASBP for alerts when major investors trade the stock.